(Chicago Tribune) — A drug recently approved by the FDA could help more than 76 million Americans who suffer from high blood pressure.
Patients who participated in the study, which compared the drug Edarbyclor to other fixed-dose drug combinations, significantly reduced their systolic blood pressure, according to the American Heart Association journal Hypertension.
Approved by the FDA in December 2011, Edarbyclor differs from other treatments by combining a receptor blocker and a diuretic in one pill, said article co-author and Downstate College of Medicine professor Dr. Michael Weber.
“Hypertension and its impact on cardiovascular health have long been studied; the goal of this particular study was to determine whether a fixed-dose combination of a well-established yet underutilized diuretic paired with a new angiotensin II receptor blocker would provide an effective option to help control hypertension,” said Weber in a press release announcing the results of the study.
Loading ...
Loading ...
I have been taking Tekturna for a few years, but as usual is not working, my top number is always higher and the bottom normal, so the doctor gave me endarbyclor, I only lasted 9 days the dizziness and vertigo got me so sick I could not even walk without looking drunk, I took the 80mg.
So I had not other choice but to get off of it and go back to Tekturna.
marg.